Virtual Screening Studies to Design Potent CDK2-Cyclin A Inhibitors

Citations Over TimeTop 11% of 2007 papers

Abstract

The cell division cycle is controlled by cyclin-dependent kinases (CDK), which consist of a catalytic subunit (CDK1-CDK8) and a regulatory subunit (cyclin A-H). Pharmacophore analysis indicates that the best inhibitor model consists of (1) two hydrogen bond acceptors, (2) one hydrogen bond donor, and (3) one hydrophobic feature. The HypoRefine pharmacophore model gave an enrichment factor of 1.31 and goodness of fit score of 0.76. Docking studies were carried out to explore the structural requirements for the CDK2-cyclin A inhibitors and to construct highly predictive models for the design of new inhibitors. Docking studies demonstrate the important role of hydrogen bond and hydrophobic interactions in determining the inhibitor-receptor binding affinity. The validated pharmacophore model is further used for retrieving the most active hits/lead from a virtual library of molecules. Subsequently, docking studies were performed on the hits, and novel series of potent leads were suggested based on the interaction energy between CDK2-cyclin A and the putative inhibitors.

Related Papers

• → Cyclin-Binding Motifs Are Essential for the Function of p21CIP1(1996)317 cited
• → Identification of a Cyclin-cdk2 Recognition Motif Present in Substrates and p21-Like Cyclin-Dependent Kinase Inhibitors(1996)375 cited
• → Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity(2001)53 cited
• → p130 and p107 Use a Conserved Domain To Inhibit Cellular Cyclin-Dependent Kinase Activity†(1997)113 cited
• → p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.(1995)251 cited